Margaret M. McCarthy
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
FAF Announces Q3 2026 Earnings Call and Receives Workplace Award. First American Financial (FAF) will host its third‑quarter 2026 earnings conference call on Thursday. The company also earned recognition as a top workplace in financial services and insurance. Analysts maintain an overweight rating, though the price target was lowered to $79. The stock trades near its 52‑week low and is currently below the 8‑touch support level at $66.04.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ALHC Faces Downgrade and Lower Target Amid Mixed CMS Ratings. Alignment Healthcare shares are trading lower after William Blair downgraded the stock to Market Perform and JP Morgan cut its price target to $10. These moves followed mixed California Star Ratings and news of network expansion, which analysts say highlight ongoing operational challenges. The stock is currently trading near its 52-week low, reflecting the negative sentiment from these recent analyst actions.
Transaction History
| MAR | ▲ Buy | Grant | 670 | $0 | 5/11/2026 | View on chart |
| FAF | ▼ Sell | Open Market | 6,630 | $468K | 4/24/2026 | View on chart |
| ALHC | ▲ Buy | Grant | 14,273 | $0 | 3/13/2026 | View on chart |
| FAF | ▲ Buy | Grant | 2,418 | $0 | 2/19/2026 | View on chart |
| FAF | ▼ Sell | Open Market | 3,500 | $230K | 8/13/2025 | View on chart |
| MAR | ▲ Buy | Grant | 868 | $0 | 5/12/2025 | View on chart |
| ALHC | ▲ Buy | Grant | 1,290 | $0 | 5/7/2025 | View on chart |
| ALHC | ▲ Buy | Grant | 12,258 | $0 | 3/13/2025 | View on chart |
| FAF | ▲ Buy | Grant | 2,522 | $0 | 2/24/2025 | View on chart |
| MAR | ▲ Buy | Grant | 837 | $0 | 5/13/2024 | View on chart |
| ALHC | ▲ Buy | Grant | 33,500 | $0 | 3/13/2024 | View on chart |
| FAF | ▲ Buy | Grant | 2,601 | $0 | 2/22/2024 | View on chart |
| MAR | ▲ Buy | Grant | 1,143 | $0 | 5/16/2023 | View on chart |
| ALHC | ▲ Buy | Grant | 21,802 | $0 | 3/8/2023 | View on chart |
| FAF | ▲ Buy | Grant | 2,457 | $0 | 2/16/2023 | View on chart |
| ALHC | ▲ Buy | Grant | 1,429 | $0 | 11/7/2022 | View on chart |
| MAR | ▲ Buy | Grant | 1,111 | $0 | 5/9/2022 | View on chart |
| ALHC | ▲ Buy | Grant | 16,556 | $0 | 3/8/2022 | View on chart |
| FAF | ▲ Buy | Grant | 2,202 | $0 | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Marriott analyst reports and Q3 2026 earnings expectations
Recent analyst reports have highlighted Marriott International alongside other prominent market players. Meanwhile, the focus is shifting toward the company's third-quarter 2026 earnings expectations. Market participants are assessing the hotel operator's performance and future outlook ahead of the upcoming report. With an average analyst target of $383.54, the upcoming results will be closely watched to see if the company can meet current market valuations.
Marriott analyst reports and Q3 2026 earnings expectations. Recent analyst reports have highlighted Marriott International alongside other prominent market players. Meanwhile, the focus is shifting toward the company's third-quarter 2026 earnings expectations. Market participants are assessing the hotel operator's performance and future outlook ahead of the upcoming report. With an average analyst target of $383.54, the upcoming results will be closely watched to see if the company can meet current market valuations.